A new therapy could improve the response to childhood acute lymphoblastic leukaemia August 06, 2025 A new therapy could improve the response to childhood acute lymphoblastic leukaemia
The Josep Carreras Institute enters a new phase to advance research into leukaemia and other blood cancers June 11, 2025 The Josep Carreras Institute enters a new phase to advance research into leukaemia and other blood cancers
Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia June 02, 2025 Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia
Dr Pablo Menéndez receives the FERO-Aladina Paediatric Cancer Award May 29, 2025 Dr Pablo Menéndez receives the FERO-Aladina Paediatric Cancer Award
Dual action immunotherapy in CAR-T cells improves control of B-ALL progression May 27, 2025 Dual action immunotherapy in CAR-T cells improves control of B-ALL progression
Dr Manel Esteller receives the Jaume Aiguader i Miró Award from the Academy of Medical and Health Sciences May 22, 2025 Dr Manel Esteller receives the Jaume Aiguader i Miró Award from the Academy of Medical and Health Sciences
A step closer to the confident production of blood stem cells for regenerative medicine May 16, 2025 A step closer to the confident production of blood stem cells for regenerative medicine
Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries May 14, 2025 Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries
Latest research on Plasmablastic Lymphoma discovers a new therapeutic opportunity May 12, 2025 Latest research on Plasmablastic Lymphoma discovers a new therapeutic opportunity
CarrerasLeaders opens its fourth call for postdoctoral researchers in blood cancers May 07, 2025 CarrerasLeaders opens its fourth call for postdoctoral researchers in blood cancers
A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies May 05, 2025 A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies
